8 research outputs found
Cloned HTLV-1+CD4+, but not CD8+, T-cells display an oncogenic miRNome
HTLV-1 persistence in vivo relies on the persistent clonal expansion of its host cells. These are CD4+ and CD8+ T cells, yet ATL is regularly CD4+. Accordingly, untransformed HTLV-1+CD4+ but not CD8+ T cells cloned from carriers cumulate the features of preleukemic cells, including multinuclearity, chromatin bridges, increased cell cycling and inappropriate telomerase activity. MicroRNAs (miR) modify the maturation of a plethora of T-cells RNA and their deregulation would therefore constitute an appropriate explanation for the Tax-dependent or -independent pleiotropic changes in the phenotype of HTLV-1+CD4+ T cells. As the miRNome of naturally infected untransformed cells has not been investigated to date, we assessed the miR expression profiling of T cells cloned from carriers. Microarray results, confirmed by quantitative RTPCR, showed that, upon infection, CD4+ and CD8+ clones yielded aberrant expression of 15 distinct miRs including miR-34b and miR-494 that were respectively over- and underexpressed in both compartments. The more prominent effect of the infection consisted in the CD4+-restricted overexpression of the cancer-related miRs miR-21, -27b and -23b associated with the CD4+-restricted downregulation of the proapoptotic miR-15 and -16. Data were extended by the analysis of 40 additional CD4+ clones (20 infected). Crossing the miRNome against the whole transcriptome data identified putative miR-targeted genes. In silico, those targeted by miR-23b and -27b defined 2 hitherto unknown pathways involving the cell cycle and genetic disorders. Therefore HTLV-1 triggers a phenotype-specific miR signature consistent with the preleukemic HTLV-1+CD4+ phenoty
Tax alters telomerase activity through both quantitative and qualitative hTERT transcriptional dysregulations
HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia
Cellular and plasma miRNA : actors and biomarkers of leukemogenesis associated with HTLV-1
Le rétrovirus HTLV-1 (Human T-cell Leukemia virus type 1) est l'agent étiologique de la leucémie T de l'adulte (ATLL) et de maladies inflammatoires. Il infecte principalement les lymphocytes T-CD4+ et T-CD8+, et se réplique essentiellement via l'expansion clonale de sa cellule hôte selon deux mécanismes distincts : HTLV-1 induit une résistance à l'apoptose des cellules T-CD8+ alors qu'il favorise la prolifération des cellules T-CD4+. Au stade chronique de l'infection, en comparaison à leur contreparties T-CD8+, les cellules T-CD4+ infectées non transformées présentent des caractéristiques pré-leucémiques telles que des anormalités génomiques et des défauts d'activation de la télomérase, ce qui explique vraisemblablement pourquoi les cellules d'ATLL sont régulièrement de phénotype T-CD4+. L'infection par HTLV-1 s'accompagne de reprogrammations drastiques du transcriptome cellulaire. Parmi elles, les modifications d'expression de micro-ARN (miARN). Les miARN sont de petits ARN non-codants qui contrôlent négativement la traduction des ARNm, et qui ont été récemment mis en évidence dans les cellules transformées par le virus, et semblent participer au maintien du phénotype tumoral. Ces données posent la question de l'origine de ces perturbations et de leurs implications dans les processus d'expansion clonale et d'initiation de la transformation des cellules infectées. Pour adresser cette question, nous avons réalisé une étude intégrée de l'expression des miARN et des ARNm de cellules T, issues de patients infectés sans malignitéHuman T-cell leukemia virus type 1 (HTLV-1) is associated with adult T-cell leukemia / lymphoma (ATLL) hat regularly occurs after a prolonged period of viral latency. In vivo, HTLV-1 replication relies on the clonal expansion of its host CD4+ and CD8+ T-cells, yet the virus causes adult T-cell leukemia / lymphoma (ATLL) that is regularly of the CD4+ phenotype. Infected cells express Tax and HBZ viral oncoproteins. Tax is mainly expressed in untransformed cells, where it promotes cell proliferation, genetic instability, and miRNA dysregulation, whereas HBZ is expressed in both untransformed and malignant T-cells where it contributes to promote cell proliferation and to silence virus expression. Here, we show that an HBZ / miRNA axis promotes cell proliferation and genetic instability. MicroRNAs (miRNAs) are evolutionarily conserved, small (~21 nucleotides), noncoding RNAs that are encoded within the genomes of almost all eukaryotes from plants to mammals. In general, miRNAs, especially in animals, post-transcriptionally regulate protein synthesis by base pairing to partially complementary sequences in the 3’ untranslated regions (UTRs) of target mRNAs. Furthermore, whereas human lymphocyte subsets are known to possess specific miRNA signatures involved in T-cell differentiation and activation, little is known about the role of miRNA dysregulation in the clonal expansion of untransformed, infected CD4+ and CD8+ T-cells in vivo, including its role, if any, in viral persistence, inflammation, genetic instability, and early leukemogenesis. To our knowledge, no study to date has assessed the effects of HBZ on the biogenesis and activity of miRNAs. In order to assess the effect of HTLV-1 infection on the miRNA expression profiles of host cells in vivo, we performed an integrated analysis of miRNA- and mRNA-expression profiles of cloned CD4+ and CD8+ T-cells derived from infected individuals without malignanc
Tax promotes the expression of the alternative spliced isoform CD44v10 by slowing down the elongating RNA polymerase II
Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
HTLV-1 bZIP Factor HBZ Promotes Cell Proliferation and Genetic Instability by Activating OncomiRs
International audienc
Deep sequencing reveals abundant non-canonical retroviral microRNAs in B-cell leukemia/lymphoma
Viral tumor models have significantly contributed to our understanding of oncogenic mechanisms.
How transforming delta-retroviruses induce malignancy however remains poorly understood,
especially as viral mRNA/protein are tightly silenced in tumors. Here, using deep sequencing of
broad windows of small RNA sizes in the Bovine Leukemia Virus ovine model of
leukemia/lymphoma, we provide in vivo evidence of the production of non-canonical Pol IIItranscribed viral microRNAs in leukemic B-cells in the complete absence of Pol II 5’ LTR-driven
transcriptional activity. Processed from a cluster of five independent self-sufficient transcriptional
units located in a proviral region dispensable for in vivo infectivity, BLV microRNAs represent ~
40 % of all microRNAs in both experimental and natural malignancy. They are subject to strong
purifying selection and associate with Argonautes, consistent with a critical function in silencing of
important cellular and/or viral targets. BLV microRNAs are strongly expressed in preleukemic and
malignant cells in which structural and regulatory gene expression is repressed, suggesting a key
role in tumor onset and progression. Understanding how Pol III-dependent microRNAs subvert
cellular and viral pathways will contribute in deciphering the intricate perturbations that underlie
malignant transformation